These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36860098)

  • 21. Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry.
    Grandone E; Tiscia GL; Mastroianno M; Larciprete G; Kovac M; Tamborini Permunian E; Lojacono A; Barcellona D; Bitsadze V; Khizroeva J; Makatsarya A; Cacciola R; Martinelli I; Bucherini E; De Stefano V; Lodigiani C; Colaizzo D; De Laurenzo A; Piazza G; Margaglione M
    Hum Reprod; 2021 Jul; 36(8):2083-2090. PubMed ID: 34195794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis.
    Akinshina S; Makatsariya A; Bitsadze V; Khizroeva J; Khamani N
    J Perinat Med; 2018 Oct; 46(8):893-899. PubMed ID: 29949514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients.
    Gojnic MG; Dugalic SV; Stefanovic AO; Stefanovic KV; Petronijevic MA; Vrzic Petronijevic SM; Pantic IV; Perovic MD; Vasiljevic BI; Milincic NM; Zaric MM; Todorovic JS; Macura M
    J Matern Fetal Neonatal Med; 2022 Nov; 35(22):4346-4353. PubMed ID: 33207979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.
    Dugalic S; Petronijevic M; Stefanovic A; Stefanovic K; Petronijevic SV; Stanisavljevic D; Kepeci SP; Milincic N; Pantic I; Perovic M
    Medicine (Baltimore); 2019 Aug; 98(34):e16883. PubMed ID: 31441864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antithrombotic therapy on the recurrence of placenta-mediated diseases in pregnancy.
    Neykova K; Dimitrova V; Dimitrov R
    J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1462-1468. PubMed ID: 32403962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound diagnosis of severe thrombotic placental damage in the second trimester: an observational study.
    Alkazaleh F; Viero S; Simchen M; Walker M; Smith G; Laskin C; Windrim R; Kingdom J
    Ultrasound Obstet Gynecol; 2004 May; 23(5):472-6. PubMed ID: 15133798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of low-molecular-weight heparin on placenta-mediated fetal growth restriction in a tertiary referral hospital: A 7-year retrospective cohort study.
    Xu J; Tang Y; Peng B; Zhang WH; Wang X
    Int J Gynaecol Obstet; 2024 Apr; 165(1):220-228. PubMed ID: 37726961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.
    Wojcieszek AM; Shepherd E; Middleton P; Lassi ZS; Wilson T; Murphy MM; Heazell AE; Ellwood DA; Silver RM; Flenady V
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012203. PubMed ID: 30556599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients?
    Rodger MA
    Thromb Res; 2013 Jan; 131 Suppl 1():S25-7. PubMed ID: 23452735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.
    Rodger MA; Betancourt MT; Clark P; Lindqvist PG; Dizon-Townson D; Said J; Seligsohn U; Carrier M; Salomon O; Greer IA
    PLoS Med; 2010 Jun; 7(6):e1000292. PubMed ID: 20563311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort.
    Chaudhry SH; Taljaard M; MacFarlane AJ; Gaudet LM; Smith GN; Rodger M; Rennicks White R; Walker MC; Wen SW
    BMC Pregnancy Childbirth; 2019 Feb; 19(1):75. PubMed ID: 30782144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    Dodd JM; McLeod A; Windrim RC; Kingdom J
    Cochrane Database Syst Rev; 2013 Jul; (7):CD006780. PubMed ID: 23884904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Thrombophilias and vascular placental pathology. A survey of the literature].
    Verspyck E; Marpeau L
    Rev Med Interne; 2005 Feb; 26(2):103-8. PubMed ID: 15710256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.
    Bujold E; Morency AM; Roberge S; Lacasse Y; Forest JC; Giguère Y
    J Obstet Gynaecol Can; 2009 Sep; 31(9):818-826. PubMed ID: 19941706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of congenital thrombophilia in women with pathological pregnancies?
    Rasmussen A; Ravn P
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):808-17. PubMed ID: 15315591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.
    Abheiden C; Van Hoorn ME; Hague WM; Kostense PJ; van Pampus MG; de Vries J
    BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications.
    Bar J; Mashiah R; Cohen-Sacher B; Hod M; Orvieto R; Ben-Rafael Z; Lahav J
    Thromb Res; 2001 Feb; 101(4):235-41. PubMed ID: 11248284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of biochemical tests of placental function for improving pregnancy outcome.
    Heazell AE; Whitworth M; Duley L; Thornton JG
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.